Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-throughput identification of bacterial β-glucuronidase inhibitors using machine learning.

Gut microbes·2026
Same author

Author Correction: The dynamics of mutational selection in cutaneous squamous carcinogenesis.

Communications biology·2026
Same author

A disease model resource reveals core principles of tissue-specific cancer evolution.

Nature·2026
Same author

Flt3L from interfollicular stroma maintains resident dendritic cells.

Trends in immunology·2026
Same author

Artificial intelligence and machine learning guided optimization in drug delivery.

Advanced drug delivery reviews·2026
Same author

The dynamics of mutational selection in cutaneous squamous carcinogenesis.

Communications biology·2026
Same journal

Author Correction: An atlas of genetic effects on cellular composition of the tumor microenvironment.

Nature immunology·2026
Same journal

Exhausted CD8<sup>+</sup> T cell fate is programmed by dynamic CTCF-mediated enhancer activation and invariant CTCF-imposed barriers.

Nature immunology·2026
Same journal

Mapping self-associating chromatin hubs identifies Id proteins as key determinants of exhausted CD8<sup>+</sup> T cell fate.

Nature immunology·2026
Same journal

Exhausted CD8<sup>+</sup> T cell subsets differ a TAD.

Nature immunology·2026
Same journal

Pregnancy-induced tissue-resident memory-like T cells contribute to tumor control in breast cancer.

Nature immunology·2026
Same journal

Mechanosensing by T cells promotes a tissue-resident memory transcriptional program.

Nature immunology·2026
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

Generation of Lymph Node-fat Pad Chimeras for the Study of Lymph Node Stromal Cell Origin
09:10

Generation of Lymph Node-fat Pad Chimeras for the Study of Lymph Node Stromal Cell Origin

Published on: December 16, 2013

6.5K

Tumor-induced stromal reprogramming drives lymph node transformation.

Angela Riedel1, David Shorthouse1, Lisa Haas1

  • 1MRC Cancer Unit, University of Cambridge, Cambridge, UK.

Nature Immunology
|July 12, 2016
PubMed
Summary
This summary is machine-generated.

Tumor-draining lymph node (TDLN) fibroblastic reticular cells (FRCs) proliferate and remodel their structure in response to cancer. This adaptation alters immune cell function, potentially promoting tumor immunosuppression.

More Related Videos

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.9K
Isolation of Murine Lymph Node Stromal Cells
05:47

Isolation of Murine Lymph Node Stromal Cells

Published on: August 19, 2014

32.5K

Related Experiment Videos

Last Updated: Mar 18, 2026

Generation of Lymph Node-fat Pad Chimeras for the Study of Lymph Node Stromal Cell Origin
09:10

Generation of Lymph Node-fat Pad Chimeras for the Study of Lymph Node Stromal Cell Origin

Published on: December 16, 2013

6.5K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.9K
Isolation of Murine Lymph Node Stromal Cells
05:47

Isolation of Murine Lymph Node Stromal Cells

Published on: August 19, 2014

32.5K

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Biology

Background:

  • Lymph node (LN) stromal cells, especially fibroblastic reticular cells (FRCs), are crucial for immune regulation and LN structure.
  • Tumor metastasis to LNs often predicts a poor prognosis.
  • The role of stromal cells in the tumor-draining lymph node (TDLN) microenvironment is not well understood.

Purpose of the Study:

  • To investigate the contribution of FRCs to the TDLN microenvironment during tumor progression.
  • To understand how tumor-derived factors influence FRC behavior and function within TDLNs.

Main Methods:

  • Comparative transcriptional analysis of FRCs from TDLNs and non-draining LNs.
  • Analysis of FRC proliferation and network remodeling in response to tumor cues.

Main Results:

  • FRCs in TDLNs proliferated and their network structure was remodeled upon exposure to tumor-derived factors.
  • Transcriptional analysis revealed reprogramming of pathways related to matrix remodeling, chemokine/cytokine signaling, and leukocyte interactions.
  • Downregulation of FRC-derived CCL21 and IL-7 was observed, leading to altered immune cell composition and localization.

Conclusions:

  • TDLN FRCs adapt to tumor presence by altering their structure and function.
  • These adaptations in the LN stroma contribute to an immunosuppressive microenvironment.
  • Understanding these stromal changes is critical for developing strategies to combat cancer metastasis.